A Phase I through Phase III oncology trial costs approximately $56.3 million and lasts for eight years. In 2012, it was reported that a typical protocol has 167 procedures with 11 trial visits over 175 days. In addition, oncology trials often have significant delays, with Phase II trials reporting a delay of over 5 months and Phase III trials reporting an almost 6 and a half month delay. In this final episode of a 3-part series, Senior Patient Recruitment Managers Tricia Buchheit and Lauren Johnson consider how rising costs and complex trial designs effect patient recruitment in oncology trials.
Cancer Research and Clinical Development Since Last ASCO
ECG Assessments During the Development of Oncology Compounds
Single-center oncology studies performed by dedicated PRA staff, combined with the High Precision QT approach of iCardiac, generates conclusive ECG…